Rznomics, Inc Rznomics Inc. Secures Australian Clinical Trial Notification for RHO-targeted Splicing Ribozyme-based RNA Editing Therapy for Retinitis Pigmentosa 07.08.2025 - 18:04:26 | prnewswire.co.uk Rznomics Inc. South Korea United Kingdom United States of America View original content:https://www.prnewswire.co.uk/news-releases/rznomics-inc-secures-australian-clinical-trial-notification-for-rho-targeted-splicing-ribozyme-based-rna-editing-therapy-for-retinitis-pigmentosa-302196598.html en | boerse | 67983881 |
